GS
IOVA icon

GTS Securities’s Iovance Biotherapeutics IOVA Stock Holding History

GTS Securities’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1K Buy
+10,004
New +$32K ﹤0.01% 1444
2024
Q4 		– Hold
0
– – – 2738
2024
Q3 		– Hold
0
– – – 4364
2024
Q2 		– Sell
-29,005
Closed -$311K – 4230
2024
Q1 		$430K Sell
29,005
-37,649
-56% -$438K 0.01% 2698
2023
Q4 		$542K Buy
66,654
+3,593
+6% +$18.8K 0.01% 2727
2023
Q3 		$287K Buy
63,061
+538
+0.9% +$3.51K 0.01% 3106
2023
Q2 		$440K Buy
+62,523
New +$448K 0.01% 713

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return